# Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve

> **NCT01490398** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 56 (actual)

## Conditions studied

- Hypertension
- Cardiovascular Risk Factors

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01490398
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2014-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490398, "Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01490398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*